CRYSTALLINE FORMS OF AN ESTROGEN RECEPTOR ANTAGONIST

Title:

CRYSTALLINE FORMS OF AN ESTROGEN RECEPTOR ANTAGONIST

Document Type and Number:

WIPO Patent Application WO/2023/225354

Kind Code:

A8

Abstract:

The present disclosure provides crystalline solid forms of an estrogen receptor (ER) inhibitor, compositions thereof and methods of treating a ER-mediated disorder.

More Like This:

JP6506763	Use of isooxazoline derivatives for the treatment or prevention of arthropod invasion in poultry
JP5511582	Methods and Compounds for Producing Dipeptidase Peptidase IV Inhibitors and Their Intermediates
JP4205577	Use of COX-2 inhibitors for the treatment of schizophrenia, delusional disorders, emotional disorders, autism or tic disorders

Inventors:

MYLES DAVID C (US)
GULLAPALLI RAMPURNA PRASAD (US)
ZHANG JING JIM (US)
ASKIN DAVID (US)
ALBERT EKATERINA (US)
WANG LIPING (US)
YANG LINA (US)
HUANG SHUYAN (US)

Application Number:

PCT/US2023/022984

Publication Date:

February 15, 2024

Filing Date:

May 19, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

OLEMA PHARMACEUTICALS INC (US)

International Classes:

A61K31/435; A61K31/38; A61K31/4353; A61K31/437; A61P35/00; A61K31/33; A61P15/12

Attorney, Agent or Firm:

D'AMATO, Erica M. et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: SALTS AND SOLID FORMS OF AN ESTROGEN RECEPTOR ANTAGONIST

Next Patent: METHOD FOR CREATING CRUDE OIL SYNTHESIZED FLUID HAVING SURFACTANT AND DEMULSIFICATION PROPERTIES